GTR 113945628
Bids Are Invited For Central Purchase - Medicines V
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
113945628
Tendering Authority
Subscribe to view
Tender No
100/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Central Purchase - Medicines V
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
18-06-2026
Closed
Work Detail
Enoxaparin Sodium Active Ingredient: Enoxaparin Sodium; Concentration/Dosage: 60 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Pree Syringe, Enoxaparin Sodium Active Ingredient: Enoxaparin Sodium; Concentration/Dosage: 80 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Pree Syringe, Human Erythropoietin - Active Ingredient: Human Erythropoietin; Concentration/Dosage: 10,000 Iu; Pharmaceutical Form: Injectable; Presentation: Ampoule O, Ertapenem Sodium - Active Ingredient: Ertapenem Sodium; Concentration/Dosage: 1 G; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation, Esketamine - Active Ingredient: Esketamine, Hydrochloride; Concentration/Dosage: 50 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule Bottle, Etomidate - Active Ingredient: Etomidate; Concentration/Dosage: 2 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 10 Ml Ampoule; Component: Everolimus - Active Ingredient: Everolimus; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Phenytoin - Active Ingredient: Phenytoin; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Fenofibrate - Active Ingredient: Fenofibrate; Concentration/Dosage: 200 Mg; Pharmaceutical Form: Hard Gelatinous Capsule; Presentation: .; Component: .;, Fentanyl - Active Ingredient: Fentanyl, Citrate Without Preservatives; Concentration/Dosage: 0.0785 Mg/Ml (0.05 Mg/Ml); Pharmaceutical Form: Injectable Solution, Citrate; Concentration/Dosage: 0.05 Mg/Ml); Pharmaceutical Form: Injectable Solution; Presentation: Fluorouracil - Active Ingredient: Fluorouracil; Concentration/Dosage: 50 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 10 Ml Ampoule Bottle, Formoterol - Active Ingredient: Formoterol, Fumarate; Concentration/Dosage: 12 Mcg; Pharmaceutical Form: Capsule; Presentation: .; Component: Inhaler;, Fulvestrant - Active Ingredient: Fulvestrant; Concentration/Dosage: 250 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Prefilled Syringe 5, Furosemide - Active Ingredient: Furosemide; Concentration/Dosage: 40 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Gabapentin - Active Ingredient: Gabapentin; Concentration/Dosage: 400 Mg; Pharmaceutical Form: Hard Gelatinous Capsule; Presentation: .; Component: .;, Gefitinib - Active Ingredient: Gefitinib; Concentration/Dosage: 250 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Glucose - Active Ingredient: Glucose; Concentration/Dosage: 5%; Pharmaceutical Form: Injectable Solution; Presentation: Bag Or Bottle 100 Ml Fech System, Sodium Hyaluronate - Active Ingredient: Sodium Hyaluronate; Concentration/Dosage: 10 Mg/Ml (1%); Pharmaceutical Form: Injectable Solution; Presentation, Hydroxychloroquine - Active Ingredient: Hydroxychloroquine, Sulfate; Concentration/Dosage: 400 Mg; Pharmaceutical Form: Coated Tablet; Presentation: Hydroxyurea - Active Ingredient: Hydroxyurea; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Hard Gelatinous Capsule; Presentation: .; Component: Ifosfamide - Active Ingredient: Ifosfamide; Concentration/Dosage: 2 G; Pharmaceutical Form: Freeze-Dried Powder; Presentation: Vial-Ampule; Component: .;, Imatinib - Active Ingredient: Imatinib, Mesylate; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component:, Mesylate; Concentration/Dosage: 400 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component:, Immuno
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
7c72206c-7c44-4139-8ac4-0e8e7dfd561c.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.